ID   UNC5A_HUMAN             Reviewed;         842 AA.
AC   Q6ZN44; B2RXE6; Q8TF26; Q96GP4;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-JUN-2023, entry version 178.
DE   RecName: Full=Netrin receptor UNC5A;
DE   AltName: Full=Protein unc-5 homolog 1;
DE   AltName: Full=Protein unc-5 homolog A;
DE   Flags: Precursor;
GN   Name=UNC5A; Synonyms=KIAA1976, UNC5H1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-404 (ISOFORM 3), AND NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 302-842 (ISOFORMS 1/2/3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 624-728.
RC   TISSUE=Brain;
RX   PubMed=11853319; DOI=10.1093/dnares/8.6.319;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXII. The
RT   complete sequences of 50 new cDNA clones which code for large proteins.";
RL   DNA Res. 8:319-327(2001).
RN   [5]
RP   INDUCTION.
RX   PubMed=12598906; DOI=10.1038/ncb943;
RA   Tanikawa C., Matsuda K., Fukuda S., Nakamura Y., Arakawa H.;
RT   "p53RDL1 regulates of p53-dependent apoptosis.";
RL   Nat. Cell Biol. 5:216-223(2003).
RN   [6]
RP   DOWN-REGULATION IN CANCER.
RX   PubMed=12655055; DOI=10.1073/pnas.0738063100;
RA   Thiebault K., Mazelin L., Pays L., Llambi F., Joly M.-O., Scoazec J.-Y.,
RA   Saurin J.-C., Romeo G., Mehlen P.;
RT   "The netrin-1 receptors UNC5H are putative tumor suppressors controlling
RT   cell death commitment.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4173-4178(2003).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 1-303, DISULFIDE BONDS,
RP   GLYCOSYLATION AT ASN-218, AND INTERACTION WITH FLRT2.
RX   PubMed=25374360; DOI=10.1016/j.neuron.2014.10.008;
RA   Seiradake E., del Toro D., Nagel D., Cop F., Haertl R., Ruff T.,
RA   Seyit-Bremer G., Harlos K., Border E.C., Acker-Palmer A., Jones E.Y.,
RA   Klein R.;
RT   "FLRT structure: balancing repulsion and cell adhesion in cortical and
RT   vascular development.";
RL   Neuron 84:370-385(2014).
CC   -!- FUNCTION: Receptor for netrin required for axon guidance. Functions in
CC       the netrin signaling pathway and promotes neurite outgrowth in response
CC       to NTN1. Mediates axon repulsion of neuronal growth cones in the
CC       developing nervous system in response to netrin. Axon repulsion in
CC       growth cones may be mediated by its association with DCC that may
CC       trigger signaling for repulsion. It also acts as a dependence receptor
CC       required for apoptosis induction when not associated with netrin
CC       ligand. {ECO:0000250|UniProtKB:O08721}.
CC   -!- SUBUNIT: Homodimer and homooligomer. Interacts with the cytoplasmic
CC       part of DCC. Interacts with MAGED1. Interacts with PRKCABP, possibly
CC       mediating some interaction with PKC (By similarity). Interacts (via
CC       extracellular domain) with FLRT2 (via extracellular domain)
CC       (PubMed:25374360). Interacts (via extracellular domain) with FLRT3 (via
CC       extracellular domain) (By similarity). {ECO:0000250|UniProtKB:O08721,
CC       ECO:0000250|UniProtKB:Q8K1S4, ECO:0000269|PubMed:25374360}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O08721};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:O08721}.
CC       Membrane raft {ECO:0000250|UniProtKB:O08721}. Cell projection, neuron
CC       projection {ECO:0000250|UniProtKB:O08721}. Note=The interaction with
CC       PRKCABP regulates its surface expression and leads to its removal from
CC       the surface of neurons and growth cones.
CC       {ECO:0000250|UniProtKB:O08721}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZN44-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZN44-2; Sequence=VSP_011694, VSP_011695;
CC       Name=3;
CC         IsoId=Q6ZN44-3; Sequence=VSP_011693;
CC   -!- INDUCTION: By p53/TP53. {ECO:0000269|PubMed:12598906}.
CC   -!- DOMAIN: The ZU5 domain mediates the interaction with MAGED1, which
CC       participates in the induction of apoptosis.
CC       {ECO:0000250|UniProtKB:O08721}.
CC   -!- PTM: Phosphorylated on cytoplasmic tyrosine residues (By similarity).
CC       Phosphorylated by PKC in vitro (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:O08721}.
CC   -!- PTM: Proteolytically cleaved by caspases during apoptosis. The cleavage
CC       does not take place when the receptor is associated with netrin ligand.
CC       Its cleavage by caspases is required to induce apoptosis.
CC       {ECO:0000250|UniProtKB:O08721}.
CC   -!- MISCELLANEOUS: Down-regulated in multiple cancers including colorectal,
CC       breast, ovary, uterus, stomach, lung, or kidney cancers.
CC       {ECO:0000269|PubMed:12655055}.
CC   -!- SIMILARITY: Belongs to the unc-5 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB85562.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK131380; BAD18531.1; -; mRNA.
DR   EMBL; AC027318; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091897; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091902; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009333; AAH09333.2; -; mRNA.
DR   EMBL; BC033727; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC157824; AAI57825.1; -; mRNA.
DR   EMBL; AB075856; BAB85562.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS34299.1; -. [Q6ZN44-1]
DR   RefSeq; NP_588610.2; NM_133369.2. [Q6ZN44-1]
DR   PDB; 4V2A; X-ray; 2.40 A; A=1-303.
DR   PDBsum; 4V2A; -.
DR   AlphaFoldDB; Q6ZN44; -.
DR   SMR; Q6ZN44; -.
DR   BioGRID; 124683; 11.
DR   IntAct; Q6ZN44; 1.
DR   STRING; 9606.ENSP00000332737; -.
DR   GlyCosmos; Q6ZN44; 3 sites, No reported glycans.
DR   GlyGen; Q6ZN44; 3 sites.
DR   iPTMnet; Q6ZN44; -.
DR   PhosphoSitePlus; Q6ZN44; -.
DR   BioMuta; UNC5A; -.
DR   DMDM; 296453000; -.
DR   MassIVE; Q6ZN44; -.
DR   PaxDb; Q6ZN44; -.
DR   PeptideAtlas; Q6ZN44; -.
DR   ProteomicsDB; 67973; -. [Q6ZN44-1]
DR   ProteomicsDB; 67974; -. [Q6ZN44-2]
DR   ProteomicsDB; 67975; -. [Q6ZN44-3]
DR   Antibodypedia; 29143; 136 antibodies from 28 providers.
DR   DNASU; 90249; -.
DR   Ensembl; ENST00000329542.9; ENSP00000332737.4; ENSG00000113763.12. [Q6ZN44-1]
DR   GeneID; 90249; -.
DR   KEGG; hsa:90249; -.
DR   MANE-Select; ENST00000329542.9; ENSP00000332737.4; NM_133369.3; NP_588610.2.
DR   UCSC; uc003mey.4; human. [Q6ZN44-1]
DR   AGR; HGNC:12567; -.
DR   CTD; 90249; -.
DR   DisGeNET; 90249; -.
DR   GeneCards; UNC5A; -.
DR   HGNC; HGNC:12567; UNC5A.
DR   HPA; ENSG00000113763; Tissue enhanced (brain, pituitary gland).
DR   MIM; 607869; gene.
DR   neXtProt; NX_Q6ZN44; -.
DR   OpenTargets; ENSG00000113763; -.
DR   PharmGKB; PA37204; -.
DR   VEuPathDB; HostDB:ENSG00000113763; -.
DR   eggNOG; KOG1480; Eukaryota.
DR   GeneTree; ENSGT00950000182815; -.
DR   HOGENOM; CLU_014383_0_0_1; -.
DR   InParanoid; Q6ZN44; -.
DR   OrthoDB; 2971005at2759; -.
DR   PhylomeDB; Q6ZN44; -.
DR   TreeFam; TF316767; -.
DR   PathwayCommons; Q6ZN44; -.
DR   Reactome; R-HSA-373752; Netrin-1 signaling.
DR   Reactome; R-HSA-418886; Netrin mediated repulsion signals.
DR   Reactome; R-HSA-418889; Caspase activation via Dependence Receptors in the absence of ligand.
DR   SignaLink; Q6ZN44; -.
DR   SIGNOR; Q6ZN44; -.
DR   BioGRID-ORCS; 90249; 14 hits in 1145 CRISPR screens.
DR   ChiTaRS; UNC5A; human.
DR   GeneWiki; UNC5A; -.
DR   GenomeRNAi; 90249; -.
DR   Pharos; Q6ZN44; Tbio.
DR   PRO; PR:Q6ZN44; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q6ZN44; protein.
DR   Bgee; ENSG00000113763; Expressed in endothelial cell and 97 other tissues.
DR   ExpressionAtlas; Q6ZN44; baseline and differential.
DR   Genevisible; Q6ZN44; HS.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0032589; C:neuron projection membrane; ISS:UniProtKB.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005042; F:netrin receptor activity; IEA:InterPro.
DR   GO; GO:0033564; P:anterior/posterior axon guidance; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0038007; P:netrin-activated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   CDD; cd08800; Death_UNC5A; 1.
DR   Gene3D; 2.60.220.30; -; 1.
DR   Gene3D; 1.10.533.10; Death Domain, Fas; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   Gene3D; 2.20.100.10; Thrombospondin type-1 (TSP1) repeat; 1.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR042155; Death_UNC5A.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   InterPro; IPR037936; UNC5.
DR   InterPro; IPR033772; UPA.
DR   InterPro; IPR000906; ZU5_dom.
DR   PANTHER; PTHR12582; NETRIN RECEPTOR UNC5; 1.
DR   PANTHER; PTHR12582:SF4; NETRIN RECEPTOR UNC5A; 1.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF17217; UPA; 1.
DR   Pfam; PF00791; ZU5; 1.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SMART; SM00218; ZU5; 1.
DR   SUPFAM; SSF47986; DEATH domain; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   SUPFAM; SSF82895; TSP-1 type 1 repeat; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50092; TSP1; 1.
DR   PROSITE; PS51145; ZU5; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Cell membrane;
KW   Cell projection; Developmental protein; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..842
FT                   /note="Netrin receptor UNC5A"
FT                   /id="PRO_0000036068"
FT   TOPO_DOM        26..306
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        307..327
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        328..842
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          44..141
FT                   /note="Ig-like"
FT   DOMAIN          155..234
FT                   /note="Ig-like C2-type"
FT   DOMAIN          242..294
FT                   /note="TSP type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          441..584
FT                   /note="ZU5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   DOMAIN          761..841
FT                   /note="Death"
FT   REGION          605..623
FT                   /note="Interaction with DCC"
FT                   /evidence="ECO:0000250"
FT   SITE            340..341
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250|UniProtKB:O08721"
FT   CARBOHYD        107
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        218
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0007744|PDB:4V2A"
FT   CARBOHYD        287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        65..126
FT                   /evidence="ECO:0007744|PDB:4V2A"
FT   DISULFID        77..124
FT                   /evidence="ECO:0007744|PDB:4V2A"
FT   DISULFID        170..221
FT                   /evidence="ECO:0007744|PDB:4V2A"
FT   DISULFID        254..288
FT                   /evidence="ECO:0007744|PDB:4V2A"
FT   DISULFID        258..293
FT                   /evidence="ECO:0007744|PDB:4V2A"
FT   DISULFID        266..278
FT                   /evidence="ECO:0007744|PDB:4V2A"
FT   VAR_SEQ         1..97
FT                   /note="MAVRPGLWPALLGIVLAAWLRGSGAQQSATVANPVPGANPDLLPHFLVEPED
FT                   VYIVKNKPVLLVCKAVPATQIFFKCNGEWVRQVDHVIERSTDGSS -> MAGTSERSLI
FT                   SSISQPKAIECFEVKKKAFLTHGRYHGSGATPPKTKDPKPETFCGQT (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011693"
FT   VAR_SEQ         296..301
FT                   /note="TASGPE -> SESSLP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_011694"
FT   VAR_SEQ         302..842
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_011695"
FT   CONFLICT        97
FT                   /note="S -> N (in Ref. 1; BAD18531)"
FT                   /evidence="ECO:0000305"
FT   STRAND          45..48
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          61..69
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          71..77
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   TURN            84..86
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          88..93
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          100..108
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   HELIX           110..115
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          118..120
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          123..129
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          158..163
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          180..185
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   TURN            192..194
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          206..208
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          211..214
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          216..224
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          229..231
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          235..241
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   HELIX           256..258
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          259..263
FT                   /evidence="ECO:0007829|PDB:4V2A"
FT   STRAND          282..287
FT                   /evidence="ECO:0007829|PDB:4V2A"
SQ   SEQUENCE   842 AA;  92932 MW;  7B209042977FE524 CRC64;
     MAVRPGLWPA LLGIVLAAWL RGSGAQQSAT VANPVPGANP DLLPHFLVEP EDVYIVKNKP
     VLLVCKAVPA TQIFFKCNGE WVRQVDHVIE RSTDGSSGLP TMEVRINVSR QQVEKVFGLE
     EYWCQCVAWS SSGTTKSQKA YIRIAYLRKN FEQEPLAKEV SLEQGIVLPC RPPEGIPPAE
     VEWLRNEDLV DPSLDPNVYI TREHSLVVRQ ARLADTANYT CVAKNIVARR RSASAAVIVY
     VDGSWSPWSK WSACGLDCTH WRSRECSDPA PRNGGEECQG TDLDTRNCTS DLCVHTASGP
     EDVALYVGLI AVAVCLVLLL LVLILVYCRK KEGLDSDVAD SSILTSGFQP VSIKPSKADN
     PHLLTIQPDL STTTTTYQGS LCPRQDGPSP KFQLTNGHLL SPLGGGRHTL HHSSPTSEAE
     EFVSRLSTQN YFRSLPRGTS NMTYGTFNFL GGRLMIPNTG ISLLIPPDAI PRGKIYEIYL
     TLHKPEDVRL PLAGCQTLLS PIVSCGPPGV LLTRPVILAM DHCGEPSPDS WSLRLKKQSC
     EGSWEDVLHL GEEAPSHLYY CQLEASACYV FTEQLGRFAL VGEALSVAAA KRLKLLLFAP
     VACTSLEYNI RVYCLHDTHD ALKEVVQLEK QLGGQLIQEP RVLHFKDSYH NLRLSIHDVP
     SSLWKSKLLV SYQEIPFYHI WNGTQRYLHC TFTLERVSPS TSDLACKLWV WQVEGDGQSF
     SINFNITKDT RFAELLALES EAGVPALVGP SAFKIPFLIR QKIISSLDPP CRRGADWRTL
     AQKLHLDSHL SFFASKPSPT AMILNLWEAR HFPNGNLSQL AAAVAGLGQP DAGLFTVSEA
     EC
//
